Volume : 09, Issue : 06, June – 2022



Authors :

Sangam Prajapati , Sailesh kumar Ghatuary, Satkar Prasad, Monika Parmar

Abstract :

Divalproex sodium is considered as the most important antiepileptic drug and widely used for treatment of epilepsy and bi-polar disorders and prophylaxis of migraine. The present work has been done to formulate bi-layered tablet of Divalproex sodium containing immediate release layer and sustained release layer. The FTIR study revealed that there was no interaction between drug and polymer and combination can be safely prepared. Both layers were prepared by wet granulation technique as poor flow property exhibited by pure drug. The immediate release layer was formulated by using sodium starch glycolate, croscarmellose sodium as superdisintegrants and evaluated for physical parameters, disintegration time and in vitro drug release. The optimized immediate release layer (IF6) with highest in vitro release of 98.11 was selected for bi-layered tablet formulation. HPMC K4M and HPMC K100M polymer used to retard the drug release from sustained release layer in different proportion and combination and evaluated for physical parameter along with in vitro drug release studies.. The optimized sustained release layer (SF8) which extends the Divalproex sodium release more than 18 hrs was selected. In vitro drug release studies were performed using USP type II apparatus (paddle method) in 900 ml of phosphate buffer pH 6.8 at 100 rpm. Finally Bi-layered tablets were prepared by double compression of selected sustained release layer and immediate release layer of Divalproex sodium. The tablets were evaluated for hardness, thickness, weight variation, friability, drug content uniformity and in vitro drug release. All the physical parameters were in acceptable limit of pharmacopeial specification. The stability studies, shown the bi-layer tablet was stable at 40°C/ 75% RH for a period of 3 months.
Keywords: Bi-layered tablet, epilepsy, wet granulation, Divalproex sodium, immediate release, sustained release.

Cite This Article:

Please cite this article in press Sangam Prajapati et al, A Novel Approach For Formulation And Evaluation Of Anticonvulsant Bi Layered Tablets., Indo Am. J. P. Sci, 2022; 09(6).,

Number of Downloads : 10


1. Notari, R., Biopharmaceutics and Clinical Pharmacokinetics, An Introduction, 3rd Ed., Marcel Dekker Inc. New York, 1980,152-54.
2. Vinay K, Prajapati SK, Girish CS, Mahendra S, Neeraj k. Sustained release matrix type drug delivery system. IRJP 2012;1(3):934-60.
3. Kumar V, Sharma A, Sharma A, Joshi G, Dhillon V. Recent Advances In Novel Drug Delivery System for Delivery Of Anti- Hypertensive Drugs. Int J D D Res.2011;3(1):252-59.
4. Basu B, Bagadiya A, Makwana S, Vipul V, Batt D,Dharamsi A. Formulation and evaluation of fast dissolving tablets of cinnarizine using superdisintegrant blends and subliming material. J Adv Pharm Technol Res. 2011;2(4):266-73.
5. http//www.pharmacopeia.cn/v29240/USP29nf24s0-c115/587.htm/
6. The Indian Pharmacopoeia, Government of India Ministry of health and family welfare, the indian pharmacopoeia commission Ghaziabad, 2014;vol.II:959.
7. Pahade AA, Jadhav VM, Kadam VJ. Formulation and Development of a Bilayer Sustained Released Tablets of Isosorbide Mononitrate. Int J Pharma Bio Sci. 2010;1(4):305-14.
8. Sahoo PK. Phamaceutical Technology,Tablets. New Delhi,2007, P 2-3
9. The Indian Pharmacopoeia, Government of India Ministry of health and family welfare, the indian Pharmacopoeia commission Ghaziabad, 2014; vol II:960-61.
10. Sandeep N. & Gupta M.M, Immediate Drug Release Dosage Form: A review. Journal of Drug Delivery & therapeutics. 2013;3(2):155-61.
11. Pahwa R, Gupta N. A Review: Superdisintegrants in the development of orally disintegrating tablets. Int J Pharm Sci Res. 2011;2(11):2767-2780.
12. Patel U, patel K, Shah D, Shah R. A review on immediate release drug delivery system. Int. j.pharm. Res. Bio-Science. 2012;1(5):37-66.
13. Chugh I, Seth N, Rana A.C. Oral sustained release drug delivery system. International Research Journal of Pharmacy 2012;3(5):57-62.